Dowden Nathan J

CIK 00018733921 companyBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001873392

Recent Transactions

50 trades

Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-09-02$5.43/sh−1,746→ 179,059 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-03-03$11.68/sh−5,144→ 180,805 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2025-03-01+90,800→ 90,800 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2025-03-01+60,800→ 185,949 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-26$16.00/sh−847→ 125,149 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-09$15.07/sh−1,904→ 125,996 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-06$15.19/sh−399→ 127,900 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-05$15.13/sh−171→ 128,299 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-04$15.42/sh−983→ 128,470 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$17.70/sh−15→ 129,453 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$16.93/sh−156→ 129,468 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-09-03$15.76/sh−483→ 129,624 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-08-16$1.74/sh+20,000→ 157,204 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-08-16$16.26/sh−26,595→ 130,609 total
Exercise/Conversion
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2024-08-16−20,000→ 64,831 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-08-16$16.70/sh−502→ 130,107 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-06$12.32/sh−1,826→ 137,204 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-05$12.28/sh−1,486→ 139,030 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-04$13.37/sh−409→ 140,516 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-04$12.42/sh−343→ 140,925 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-01+60,000→ 141,268 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2024-03-01+33,100→ 81,268 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2024-03-01+50,100→ 50,100 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-06$14.01/sh−59→ 48,168 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-06$13.43/sh−913→ 48,227 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-05$14.46/sh−436→ 49,140 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-09-01+21,500→ 21,500 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-09-01+14,200→ 49,576 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-07-11$18.05/sh−3,897→ 35,376 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-07-10$18.00/sh−3,200→ 39,273 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-06-22$16.02/sh−7,097→ 42,473 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-06-20$14.94/sh−8,885→ 49,570 total
Tax Payment
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-02$11.60/sh−1,028→ 72,655 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-01+14,200→ 58,455 total
Award
Entrada Therapeutics, Inc.$TRDA
Common Stock
2023-03-01+28,400→ 73,683 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-03-01+21,500→ 21,500 total
Award
Entrada Therapeutics, Inc.$TRDA
Stock Option (Right to Buy)
2023-03-01+43,000→ 43,000 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-31$24.05/sh−2,100→ 45,283 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-25$20.97/sh−5,414→ 48,283 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-25$20.10/sh−3,034→ 53,697 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-25$21.85/sh−900→ 47,383 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-24$18.88/sh−1,102→ 58,033 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-24$19.66/sh−1,302→ 56,731 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-21$18.29/sh−2,771→ 59,135 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-10-20$18.07/sh−905→ 61,906 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-09-26$15.32/sh−1,329→ 63,026 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-09-26$16.25/sh−215→ 62,811 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-09-23$15.07/sh−1,018→ 64,355 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-09-21$15.13/sh−3,275→ 65,373 total
Sale
Entrada Therapeutics, Inc.$TRDA
Common Stock
2022-09-15$15.01/sh−100→ 68,648 total

Companies

Entrada Therapeutics, Inc.
President & COO
$TRDA

Recent Filings

Address

C/O ENTRADA THERAPEUTICS, INC. ONE DESIGN CENTER PLACE, SUITE 17-500

BOSTON, MA, 02210

View on SEC.gov